5VM
COGT icon

5AM Venture Management’s Cogent Biosciences COGT Stock Holding History

5AM Venture Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-561,854
Closed -$6.07M – 32
2024
Q3 		$6.07M Sell
561,854
-228,586
-29% -$2.23M 1.25% 20
2024
Q2 		$6.66M Hold
790,440
– – 1.49% 19
2024
Q1 		$5.31M Hold
790,440
– – 1.19% 24
2023
Q4 		$4.65M Hold
790,440
– – 1.23% 21
2023
Q3 		$7.71M Hold
790,440
– – 2.22% 14
2023
Q2 		$9.36M Hold
790,440
– – 2.33% 12
2023
Q1 		$8.53M Hold
790,440
– – 2.18% 12
2022
Q4 		$9.14M Hold
790,440
– – 2.46% 14
2022
Q3 		$11.8M Sell
790,440
-338,760
-30% -$4.64M 2.26% 12
2022
Q2 		$10.2M Buy
1,129,200
+417,788
+59% +$2.85M 2.52% 13
2022
Q1 		$5.33M Buy
+711,412
New +$4.95M 1.16% 16

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

5AM Venture Management's COGT Position: Q4 2024 in Review

5AM Venture Management sold out of Cogent Biosciences (COGT) in Q4 2024, closing a stake of 561,854 shares — an estimated $6.07M sold.

5AM Venture Management first reported a position in COGT in Q1 2022 and held it in 11 quarters. The position peaked at $11.8M in Q3 2022. 176 funds tracked by Wall St. Rank hold COGT as of Q4 2024.

  • 5AM Venture Management reported no remaining Cogent Biosciences position as of Q4 2024 after selling out during the quarter.
  • 5AM Venture Management sold 561,854 Cogent Biosciences shares in Q4 2024, an estimated $6.07M.
  • 5AM Venture Management first reported a position in Cogent Biosciences in Q1 2022 and held it in 11 quarters.
  • 5AM Venture Management's Cogent Biosciences position peaked at $11.8M in Q3 2022.
  • 176 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2024.

Based on 5AM Venture Management's 13F filing for Q4 2024, filed 14 Feb 2025.